SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-161721
Filing Date
2018-05-14
Accepted
2018-05-14 09:10:33
Documents
3
Period of Report
2018-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d578340d8k.htm 8-K 14756
2 EX-99.1 d578340dex991.htm EX-99.1 30641
3 GRAPHIC g578340g44t99.jpg GRAPHIC 4394
  Complete submission text file 0001193125-18-161721.txt   52835
Mailing Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362
Business Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362 (818) 629-2256
Sienna Biopharmaceuticals, Inc. (Filer) CIK: 0001656328 (see all company filings)

IRS No.: 273364627 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38155 | Film No.: 18828890
SIC: 2834 Pharmaceutical Preparations